AfricInvest Exits Polymedic to NBK Capital Partners

06 Jan 2020

AfricInvest, a leading pan-African private equity platform, is pleased to announce that its Maghreb Private Equity Fund III (MPEF III) has exited from its investment in Polymedic, a leading generics manufacturing company headquartered in Casablanca, Morocco, which owns a diverse portfolio of over 200 registered products across 12 therapeutic areas. NBK Capital Partners, an alternative investments firm that provides flexible growth capital to mid-sized companies in the Middle East, North Africa and Turkey has acquired AfricInvest’s stake.

NBK Capital Partners, alongside Foursan Capital Partners, an institutional private equity fund based in Amman, Jordan will now own majority stake in Polymedic, while Dr. Mohamed Houbachi, Polymedic CEO, will retain a significant stake. He will remain CEO of Polymedic and will partner with NBK Capital Partners and Foursan Group on the company’s next stage of growth.

Brahim El Jaï, Executive Partner at AfricInvest said, “We have been delighted to support Polymedic’s growth into a strong and sustainable business with best-in-class management and a clear vision for continued advancement. It has been both a pleasure and an honor to partner with Dr. Houbachi, whose prescience and entrepreneurial spirit have been essential components of the company’s success to date. We look forward to Polymedic’s bright future as it begins its new partnership with NBK Capital Partners.”

Yaser Moustafa, Senior Managing Director of NBK Capital Partners added, “This acquisition is very exciting for NBK Capital Partners, as it allows us to grow our presence in a sector that is buoyed by positive developments. Partnering with industry experts such as Dr. Houbachi who carry immense knowledge and experience in the pharmaceutical sector is a great opportunity for us and we look forward to continuing to drive growth through similar successful collaborations to increase our presence in Morocco and North Africa.”

Nashat Masri, Partner at Foursan, said, “The concept of aggregating pharmaceutical assets in various countries under a single investment platform has enormous synergistic potential, especially as regulatory environments across the region become increasingly sophisticated and as countries continue to move toward favouring their home industries.”

Dr. Mohamed Houbachi, CEO of Polymedic, added, “I am excited to partner with NBK Capital Partners and look forward to further growing and expanding the business in Morocco and West Africa. I am confident that being part of a regional platform will enable the business to further develop and leverage the tools available to us.”

-END-

« Back to Member News

We’re on Clubhouse! Join the AVCA PE & VC Lounge for conversations about key trends driving African investment and… https://t.co/M7qS2knmrz

We look forward to welcoming @AbasiEneobong of @weare54gene and Biju Mohandas of @LeapFrogInvest at the upcoming AV… https://t.co/3Z72z8Vknw

RT @nickodonohoe: It’s important for us to consider the disproportionate economic impact the pandemic is having on women. Thanks to @AVCA_A…

Calling all first-time fund managers and GPs currently fundraising! We have limited slots available for the Pitch C… https://t.co/NhrxeB3fGA

Don't miss the panel 'Evolving Themes and Emerging Opportunities' with Adenia Partners' Managing Partner, Stephane… https://t.co/q6DVq0rNVZ

;